Publications by authors named "Grigory Krivoborodov"
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Pierre Denys Juan Carlos Castaño Botero Ricardo Luis Vita Nunes Barton Wachs Cristiano Mendes Gomes Grigory Krivoborodov
Neurourol Urodyn
January 2023
Background: Neurogenic detrusor overactivity incontinence (NDOI) is often inadequately managed with oral therapy.
Objective: To assess efficacy and safety of abobotulinumtoxinA (aboBoNT-A; Dysport®; Ipsen Ltd.) according to etiology of NDOI.